These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 39183338)
1. KCNJ16-depleted kidney organoids recapitulate tubulopathy and lipid recovery upon statins treatment. Sendino Garví E; van Slobbe GJJ; Zaal EA; de Baaij JHF; Hoenderop JG; Masereeuw R; Janssen MJ; van Genderen AM Stem Cell Res Ther; 2024 Aug; 15(1):268. PubMed ID: 39183338 [TBL] [Abstract][Full Text] [Related]
2. Defects in KCNJ16 Cause a Novel Tubulopathy with Hypokalemia, Salt Wasting, Disturbed Acid-Base Homeostasis, and Sensorineural Deafness. Schlingmann KP; Renigunta A; Hoorn EJ; Forst AL; Renigunta V; Atanasov V; Mahendran S; Barakat TS; Gillion V; Godefroid N; Brooks AS; Lugtenberg D; Lake J; Debaix H; Rudin C; Knebelmann B; Tellier S; Rousset-Rouvière C; Viering D; de Baaij JHF; Weber S; Palygin O; Staruschenko A; Kleta R; Houillier P; Bockenhauer D; Devuyst O; Vargas-Poussou R; Warth R; Zdebik AA; Konrad M J Am Soc Nephrol; 2021 Jun; 32(6):1498-1512. PubMed ID: 33811157 [TBL] [Abstract][Full Text] [Related]
3. Renal phenotype in mice lacking the Kir5.1 (Kcnj16) K+ channel subunit contrasts with that observed in SeSAME/EAST syndrome. Paulais M; Bloch-Faure M; Picard N; Jacques T; Ramakrishnan SK; Keck M; Sohet F; Eladari D; Houillier P; Lourdel S; Teulon J; Tucker SJ Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10361-6. PubMed ID: 21633011 [TBL] [Abstract][Full Text] [Related]
4. Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease. Kompatscher A; de Baaij JHF; Aboudehen K; Hoefnagels APWM; Igarashi P; Bindels RJM; Veenstra GJC; Hoenderop JGJ Kidney Int; 2017 Nov; 92(5):1145-1156. PubMed ID: 28577853 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel variant in KCNJ16, encoding K Xu B; Levchenko V; Bohovyk R; Ahrari A; Geurts AM; Sency V; Xin B; Wang H; Staruschenko A Physiol Rep; 2024 Oct; 12(20):e70083. PubMed ID: 39414394 [TBL] [Abstract][Full Text] [Related]
6. Role of K Xu B; Levchenko V; Zietara A; Fan S; Klemens CA; Staruschenko A Am J Pathol; 2024 Sep; ():. PubMed ID: 39341364 [TBL] [Abstract][Full Text] [Related]
7. Deletion of Kir5.1 Impairs Renal Ability to Excrete Potassium during Increased Dietary Potassium Intake. Wu P; Gao ZX; Zhang DD; Su XT; Wang WH; Lin DH J Am Soc Nephrol; 2019 Aug; 30(8):1425-1438. PubMed ID: 31239388 [TBL] [Abstract][Full Text] [Related]
8. Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport. Lin DH; Duan XP; Zheng JY; Wang WH Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):479-485. PubMed ID: 35894283 [TBL] [Abstract][Full Text] [Related]